N/A N=57 Supportive Care

SDOCT-GMPE Software

Glaucoma

Bottom Line

View on ClinicalTrials.gov: NCT02235454 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jul 2017

Primary outcome: Primary: Retinal Nerve Fiber Layer (RNFL) Thickness Correlation Width Global Bruch's Membrane Opening-minimum Rim Width (BMO-MRW) — 0.70 correlation coefficient

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: SDOCT-GMPE software (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Duke University
Primary completion: Aug 2016

Outcome Measures

Outcome	Result	p-value
PRIMARY Retinal Nerve Fiber Layer (RNFL) Thickness Correlation Width Global Bruch's Membrane Opening-minimum Rim Width (BMO-MRW)	0.70	—

Summary

The investigators prospectively evaluate the new glaucoma premium edition (GMPE) software for spectral domain optical coherence tomography (SDOCT) and if this software is superior to the conventional one that is currently used for SDOCT.

Eligibility Criteria

Inclusion Criteria

capable and willing to provide consent
history of clinically-diagnosed glaucoma
at least 18 years of age

Exclusion Criteria

unable or unwilling to give consent
under 18 years of age

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02235454). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.